Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 0.00 |
| Cost of Revenue | 191.90K | 98.40K | 264.00K | -37.20K | 64.90K |
| Gross Profit | -191.90K | -98.40K | -264.00K | 37.20K | -64.90K |
| SG&A Expenses | 613.70K | 1.06M | 1.19M | 863.70K | 659.40K |
| Depreciation & Amortization | 27.90K | 53.50K | -- | 3.30K | 29.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 833.50K | 1.21M | 1.45M | 829.90K | 754.20K |
| Operating Income | -833.50K | -1.21M | -1.45M | -829.90K | -754.20K |
| Income Before Tax | -1.23M | -1.28M | 11.30M | -1.04M | -1.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.23M | -1.28M | 11.30M | -1.04M | -1.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.23M | -1.28M | 11.30M | -1.04M | -1.02M |
| EBIT | -833.50K | -1.21M | -1.45M | -829.90K | -754.20K |
| EBITDA | -805.60K | -1.20M | -1.41M | -826.50K | -724.30K |
| EPS Basic | -0.23 | -0.36 | 3.23 | -0.29 | -0.29 |
| Normalized Basic EPS | -0.14 | -0.24 | 0.30 | -0.18 | -0.18 |
| EPS Diluted | -0.24 | -0.37 | 3.00 | -0.30 | -0.30 |
| Normalized Diluted EPS | -0.14 | -0.24 | 0.28 | -0.18 | -0.18 |
| Average Basic Shares Outstanding | 5.25M | 3.55M | 3.49M | 3.56M | 3.49M |
| Average Diluted Shares Outstanding | 5.25M | 3.55M | 3.77M | 3.56M | 3.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |